NCT05593107View on ClinicalTrials.gov

68Ga-N188 PET/CT Imaging in Malignancy

NARecruitingINTERVENTIONAL

Enrollment

203

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Neoplasms

Interventions

DRUG

[68Ga]N188

68Ga-N188 is injected intravenously with a dose of 0.06-0.08 mCi/kg.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER